- A microfluidic fluidized bed to capture, amplify and detect bacteria from raw samples. Methods in Cell Biology. 2018
- A new microfluidic approach for the one-step capture, amplification and label-free quantification of bacteria from raw samples. Chemical Science. 2017
- Rapid screening for specific glycosylation and pathogen interactions on a 78 species avian egg white glycoprotein microarray. Nature Scientific Reports. 2017.
- Exploitation of Glycobiology in Anti-Adhesion Approaches against Biothreat Agents. Journal of Bioterrorism & Biodefense. 2016
- Assessing Bacterial Interactions Using Carbohydrate-Based Microarrays. MDPI Microarrays. 2015
ARTICLES / PRESS RELEASES
- ‘Living Velcro’ used to trap viruses by Elaine O’Regan. Business Post; Feb 11, 2022.
- Local medtech company develops mask spray which blocks 99 per cent of pathogens. Galway Advertiser; Mar 11, 2021.
- Green Innovator: Aquila lancia la prima salvietta anti-coronavirus 100% naturale. Enterprise Ireland, The Irish Advantage Italian Version
- Galway medtech develops mask spray to block 99% of pathogens by Lisa Ardill. Siliconrepublic; Mar 8, 2021.
- NUIG spin-out develops mask spray that blocks 99% of pathogens. Galway Bay FM; Mar 8, 2021.
- Medtech mask spray blocks 99% of pathogens
- Irish Innovation in Wipes and Masks Could Help Battle Emerging Coronavirus Crisis. NUI Galway Marketing & Communications Office; Jan 27, 2021.
- Aquila Bioscience has developed a ground-breaking new barrier spray making re-usable masks up to 99% effective at blocking airborne pathogens and particles. Marketing & Communications Office; Mar 11, 2021
- Innovation is key in battle against Covid-19 by Sylvia Thompson. Irish Times; May 12, 2020.
- Irish Company Develop Technology Proven to Remove 99.99% of Coronavirus from Human Skin. Marketing & Communications Office; October 28, 2020.
- Aquila Bioscience is selected for EIC Accelerator Funding. European Commission; June 8, 2020.
- My secondment in AquilaBioscience in Galway – Pathsense. EU ITN project
- An emerging Irish technology may be key to containing the Wuhan coronavirus. GRIPT; Feb 27, 2020.
- First consignment of Galway-manufactured wipe that can help fight SARS-CoV-2 delivered to Defence Forces. Galway Bay FM; April 14, 2020.
- Higher Education Research Activity in response to SARS-CoV-2: Higher Education Research Activity in response to SARS-CoV-2 by Maura O’Shea. HEA Newsletter; May 27, 2020.
- NOVEL DECONTAMINATION WIPE TO PREVENT SPREAD OF SARS-CoV-2. Irish Defence Forces Newsletter; April 2020.
- 07-2020-01/2023, EIC Accelerator (H2020-EIC-SMEInst-2018-2020-3), COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus (Grant agreement ID: 959436), EU contribution: €1,941k (Overall budget: €2,773k)
- 04/2017-04/2021, ITN PathSense (Pathogen Sensing), ABL cost: none/student secondments
- 01/2018 – 06/2018, Glyco-DeCon Feasibility Study (SMEInst-13-2016-2017 Phase I) to verify financial feasibility and review the Intellectual property landscape, EU H2020 SMEInst ABL cost: €71k (total cost €71k)
- 04/2015 – 04/2017, DCLAW: Decontamination by Carbohydrate Lectin Affinity Wipes European Defence Agency, ABL cost: €132k (total cost €248k)
- 05/2014 – 04/2017, NAPES: Next Generation Analytical Platforms for Environmental Sensing, EU FP7-NMP, ABL cost: €480k (total cost €4,539k)